*In Vitro* Assessment of Antioxidant Capacity, Potential to Induce Autophagy/Mitophagy, and Mitochondrial Turnover of Natural Compounds for Cytotoxicity Studies

*Madhulika Tripathi, Manish Kumar Verma and Brijesh Kumar Singh*

## **Abstract**

The dynamic process of intracellular reduction-oxidation status (redox homeostasis) is influenced by various factors, with mitochondria being one of the most significant contributors. Mitochondria play a crucial role in the bioenergetic pathway, fulfilling the metabolic energy demands of cells. To maintain increased energy requirements, mitochondrial biogenesis and fusion are employed, while decreased energy demands or damaged mitochondria are addressed through fission and autophagic removal, known as mitophagy. Any disruption in these adaptive responses can compromise redox homeostasis and cellular function, and make cells more vulnerable to oxidative stress, resulting in oxidative DNA damage, inflammatory responses, and apoptotic/anti-apoptotic reactions. Such dysregulation contributes to the development of "free radical diseases" like metabolic disorders and cancer. Traditional medicines and herbs (possessing antioxidant and autophagic properties) have been utilized for centuries in the treatment of various diseases; however, it is only recently that researchers have begun to investigate their molecular, cellular, and tissue-level modes of action. Nevertheless, concerns about their cytotoxicity have also arisen. This manuscript focuses on the current technological advancements in assessing the properties of plant-based natural compounds. Both cell-free and cell-based methods are employed to evaluate the therapeutic potential of these compounds, allowing for their scientific evaluation and validation.

**Keywords:** antioxidant potential, autophagy, mitophagy, cytotoxicity, natural compound

## **1. Introduction**

Past decades have perceived growing interest of studies investigating the role of Reactive Oxygen Species (ROS) and its amelioration with natural products [1–4]. There are increasing evidences that suggest increased oxidative stress from ROS plays critical role in several pathophysiologies and causes Endoplasmic Reticulum stress and mitochondrial dysfunction. The intracellular redox balance (reduction–oxidation status) is a dynamic system which maintains the cellular homeostasis and may change via many factors [5–7]. Mitochondria, being one of the most important organelles, play a crucial role in maintaining intracellular source of energy. Any alteration in mitochondrial dynamics can cause an overproduction of ROS, which urges the induction of oxidative DNA damage and up- or down-regulation of phosphatases, proliferative/anti-proliferative factors, apoptotic/anti-apoptotic factors, etc. [5]. However, physiological levels of ROS are crucial for a proper cell function (i.e. intracellular signaling, inflammation, and immune function) [8]. Moreover, mitochondrial dysfunction and redox imbalance can contribute to a wide range of pathologies under a wide group termed as "free radical diseases" (e.g. cancer, neurodegeneration, atherosclerosis, inflammation, etc.) [5]. Altered cellular homeostasis by oncogenes, mitochondrial dysfunction, and/or oxidative stress leads to an increased genomic instability and the target cells can adapt to the changing environment [9].

Oxygen is vital for most unicellular and multicellular organisms, paradoxically it is also a key in generating Reactive Oxygen and Nitrogen Species (ROS/RNS). Endogenously, ROS are normal by-products of mitochondrial metabolism and energy production [5]. Exogenous sources include smoking, pollution, physical exercise etc. In metabolic disorders or cancer, ROS/RNS homeostasis compromises leading to oxidative stress [10, 11]. To maintain the fine balance and to counteract the harmful effects taking place in the cell, biological system has evolved itself with some strategies like prevention of oxidative damage, repair mechanism, finally the most important is the antioxidant defense mechanisms. Cells are protected from oxidative stress by several antioxidant mechanisms both inside and outside the mitochondria. These include manganese superoxide dismutase (Mn-SOD) in the mitochondria, copper/zinc-SOD in the cytosol, and extracellular-SOD in the interstitium [12]. Classically antioxidants were defined as molecules that inhibit or prevent oxidation of a substrate and are required to control any excess in these ROS/RNS and to maintain Redox homeostasis.

Plant-based natural products have been basis of treatment of many human diseases. The extracts of several plants have been used as therapeutic agents. Spices and herbs that are sources of natural antioxidants, can protect against oxidative stress and thus play preventive role in many diseases [13]. The medicinal properties of folk plants are mainly attributed to the presence of flavonoids, other organic, and inorganic compounds such as coumarins, phenolic acids, and antioxidant micronutrients and are able to counter various metabolic disorders, cancers, and COVID-19 [14–17].

#### **1.1 Role of mitochondrial oxidative stress in metabolic disorders and cancer**

Metabolism refers to breaking down of food, in a highly-regulated manner, into simpler units of proteins, carbohydrates, and fats in order to generate energy for the organism. Metabolic syndrome is considered to be a progressive pathophysiological state which is clinically manifested by a cluster of interrelated risk factors such as abdominal obesity, atherogenic dyslipidemia, increased blood pressure, insulin resistance, and pro-inflammatory response [18, 19]. "Cancer metabolism" refers to the alterations in

#### In Vitro *Assessment of Antioxidant Capacity, Potential to Induce Autophagy/Mitophagy… DOI: http://dx.doi.org/10.5772/intechopen.112278*

cellular metabolic pathways that are evident in cancer cells compared with most normal tissue cells. Major metabolic changes in cancer cells are increased glycolysis and reduced oxidative phosphorylation coupled with increased biosynthetic intermediates needed for cell growth and proliferation [20]. Likewise, the most common cellular patho-physiologies of metabolic disorders are increased oxidative stress, impaired mitochondrial functions, and cellular repair mechanism (autophagy and apoptosis), etc. [21–23].

Mitochondria are importantly placed in the history of cancer and have been attributed to play a crucial role in metabolic disorders [24, 25]. Although, mitochondria are the center for bioenergetics and biosynthesis pathways, they have also become a critical source of oxidative stress by generating ampule amount of superoxide in ETC [5]. Hence, mitochondrial redox control is utmost important for oxidative phosphorylation, ATP synthesis, and ROS production. The production of ROS in mitochondria is tightly regulated by the mitochondrial superoxide dismutase (SOD2) and glutathione-peroxidase (GPx), as well as by catalase and non-enzymatic antioxidants [5]. Excessive mitochondrial ROS and mitochondrial dysfunctions can promote metabolic−/age-related disorders (NAFLD, diabetes, atherosclerosis, neurodegeneration, etc.) and cancer through suppression of complex I, induction of oxidative mitochondrial DNA damage, increased excessive calcium ion influx, alterations in autophagy [5, 26–28]. Therefore, Phyto molecules/plant-based compounds having antioxidant potential and/or autophagic induction may provide beneficial effects in above-mentioned diseases that are associated with ROS and oxidative stress.

#### **1.2 Therapeutic potential of natural compounds in metabolic disorders and cancer**

Natural products have always been of immense importance in health and disease treatment throughout the human evolution [1–4]. Traditionally several natural products have been used to treat different types of human illnesses including general injuries, wound healing, and pain [29, 30]. Natural products have been shown to have pharmacological properties to regulate cell signaling pathways that cause mitogenic and cytotoxic reactions leading to disease pathologies. Usage of modern technological tools such as genomics, proteomics, and metabolomics paved wider use of these natural products. Nowadays, mostly natural products are processed and have been developed as potential pharmacological agents with effective anti-oxidative, antimitotic, anti-microbial, anti-inflammatory, anti-angiogenic, and anti-carcinogenic properties [13, 31]. Different civilizations have been relying on plants or plant-based products to improve health. This also holds remarkable therapeutic alternatives to synthetic drugs. Millions of Europeans, Africans, Asians, Australians, and North Americans use plant-based medicine system as health supplements for their general health wellbeing. However, in developing countries, ayurveda and TCM, the traditional Indian and Chinese medicine is often the primary source of health care [32].

Many medicinal plants and natural products are considered by the public as a safe, natural, and cost-effective alternative to synthetic drugs without explicit proof by randomized controlled clinical trials [32]. Recently, there is an added attention in the validation of the efficacy and safety of natural products [32].

Several preclinical studies and non-scientific data accumulated over decades of research confirm the use of medicinal plants and plant-based products in the treatment or prevention of metabolic disorders. These products have gained popularity in western societies; however, their expected health benefits are often not backed by rigorous clinical trials. Therefore, it is essential to provide robust scientific evidence on their clinical efficacy and safety.

## **2.** *In vitro* **tools and techniques for the assessments of natural compounds**

## **2.1 Assessment of antioxidant potential of plant extract/natural compound in a cell free system**

## *2.1.1 Total antioxidant capacity by ABTS decolorization assay*

Principle: The assay is based on the ability of antioxidant molecules to quench the stable ABTS (2,2´-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid)) radical [33]. A blue-green solution of ABTS cation radical (ABTS•+) is formed by the loss of an electron from stable ABTS radical and absorbs at 743 nm. In the assay, addition of Trolox decolorizes the solution resulted by the quenching the hydrogen atom by nitrogen atom.

Methodology (for 96-well plate format):


## *2.1.2 Nitric oxide (NO) quenching capacity*

Principle: Nitric oxide (NO) interacted with oxygen to produce stable products, nitrite and nitrate that are key to generate RNS. Scavenger of NO competed with oxygen, leading to a reduced production of nitrite. The concentration of nitrite assays by the method of Feelisch and Noack [34] by reacting nitrite with griess reagent with which it forms a stable product which is measured at 542 nm on a spectrophotometer.

Methodology (for 96-well plate format):


In Vitro *Assessment of Antioxidant Capacity, Potential to Induce Autophagy/Mitophagy… DOI: http://dx.doi.org/10.5772/intechopen.112278*

vi.Capacity of extract to inhibit this stable product is taken as NO quenching capacity/mg extract.

Application: Oxidative stress plays a key role on pathophysiology and aging [35–37]. Many phytochemicals/active compounds (polyphenols, flavonoids, terpenes, etc.) have antioxidant properties that are responsible for therapeutic effects of plants/herbs [14, 32]. Evaluating antioxidant potential of herbal/plant extract is the easy and very useful way to validate extract's therapeutic efficacy toward oxidative stress.

#### **2.2 Assessment of autophagy, lipophagy, and mitophagy using** *in vitro* **cell system**

#### *2.2.1 Analysis of autophagy by Western blotting*

Introduction and principle: Autophagy is a catabolic cellular multistep process [38]. In autophagy, most commonly known as macroautophagy, targeted cytoplasmic constituents (such as damaged macromolecules and organelles) are isolated from the rest of the cell within a double-membraned vesicle called autophagosome. These autophagosome eventually fuses with lysosomes forming autolysosome and the contents inside are degraded under acidic environment and get recycled. Non-selective autophagy or macroautophagy is dissociated with other forms of specific autophagy processes such mitophagy (autophagic degradation of mitochondria), lipophagy (autophagic degradation of lipids), ERphagy (autophagic degradation of ER), etc.

Autophagy is executed by several autophagy-related (Atg) genes initially identified in Saccharomyces cerevisiae and later validated in mammalian systems [39]. During initiation of autophagy, two ubiquitin-like proteins Atg12 to Atg5 covalently conjugate and then bind to Atg16L1 to form an E3-like complex which functions as part of the second ubiquitin-like conjugation system. This complex binds and activates Atg3, which covalently attaches mammalian homologs of the ubiquitin-like protein Atg8/LC3B to the lipid phosphatidylethanolamine (PE) on the surface of autophagosomes after conversion from LC3B-I to LC3B-II. This lipidated LC3B (LC3B-II) closes the autophagosomes and enables docking of cargospecific adaptor proteins such as Sequestosome-1/p62. The completed autophagosome then fuses with a lysosome through the actions of multiple proteins. After autophagosome-lysosome fusion, LC3B that is retained on the outer side is cleaved off and recycled whereas inside the vesicle along with Sequestosome-1/p62 gets degraded. Hence, Western blot analysis of the rate of accumulation of LC3B-II (autophagic flux) under lysosomal inhibition (using inhibitors such as chloroquine, Bafilomycin A1 etc.) is the most appropriate way to study autophagy and take as autophagic marker [40].

Methodology:


iii.Treat groups iii and iv with extract or natural compound for 24–72 h.


Analysis of LC3B-II western blot: As shown in the (**Figure 1A**), there will be 3 cases of LC3B-II western blot image.

Step-I: Take normalized densitometric ratios for basal autophagy (yellow box): i.e. lanes 2:1.

Step-II: Take normalized densitometric ratios for autophagy under treatment (green box): i.e. lanes 4:3.

Step-III: Compare the ratios from basal autophagy (step-I) vs. autophagy under treatment (step-II) for significance.

Interpretation of LC3B-II western blot:

As mentioned earlier that autophagy is a kinetic process. However, during the analysis, the expression of cellular LC3B-II at a given time point is a static and unable to represent the rate of autophagosome synthesis and degradation after lysosomal fusion. i.e. autophagy flux. Thus, to better analyze this, use of lysosomal inhibitors is important. This enables us to analyze any increase in the LC3B-II in the presence of a lysosomal inhibitor representing autophagy induction or autophagosome biogenesis before lysosomal activity was blocked. Hence, as shown in the **Figure 1A**, there will be 3 cases (**Figure 1B-D**) of autophagy flux according to LC3B-II expression before and after the treatment of lysosomal inhibitors.

• Case-1: Activation of autophagic flux by treatment X.

If relative LC3B-II protein expression is higher under treatment when compared to untreated group (as shown in **Figure 1B** by red dotted line), and it is further increased after lysosomal inhibition (as shown in Figure B by double-head arrows) in treated group compared to untreated group.

• Case-2: Inhibition of autophagic flux by treatment X at autophagosome formation step (i.e. early block).

If relative LC3B-II protein expression is lower under treatment when compared to untreated group (as shown in **Figure 1B** by red dotted line), and it is further decreased or unchanged after lysosomal inhibition (as shown in **Figure 2B** by doublehead arrows) in treated group compared to untreated group.


In Vitro *Assessment of Antioxidant Capacity, Potential to Induce Autophagy/Mitophagy… DOI: http://dx.doi.org/10.5772/intechopen.112278*

### *2.2.2 Analysis of autophagy and mitophagy by fluorescence microscopy*

Introduction and principle: To analyze the progression of autophagy/mitophagy from autophagome/mitophagosomes to lysosomes, recently developed reporter

**Figure 2.**

*RFP-GFP fusion plasmids to study autophagic/mitophagic flux under fluorescent microscope.*

plasmids (**Figure 2**), that are tandem-tagged RFP-EGFP protein fused and cloned with LC3B (to analyze autophagy) or mitochondrial localization signal (MLS) typically COX-IV (also called mitoRFP-GFP plasmid; to analyze mitophagy), have been used, which exploit the differential stabilities of RFP and GFP in an acidic environment [40]. Green GFP signals are quenched in acidic pH, whereas RFP signals can be visualized in both autophagosome and acidic autophagolysosome, thus an increase in RFP fluorescence in the lysosomes indicates completion of the mitophagy process. However, at basal, yellow signals indicate merged images of GFP and RFP signals for only autophagosome containing mitochondria. Therefore, the formation of red puncta in treatment groups will indicate increased autophagic/mitophagic flux over untreated cells which will show yellow puncta.

Methodology:

i.Seed the cells in appropriate density in chambered slides and incubate at 370C and 5% CO2: 95% Air environment inside an incubator.

In Vitro *Assessment of Antioxidant Capacity, Potential to Induce Autophagy/Mitophagy… DOI: http://dx.doi.org/10.5772/intechopen.112278*

ii.Plasmid transfection: At 70–80% confluency, make two groups as i. untreated and ii. Treatment X (extract or natural compound), then use 0.5 μg plasmid and transfection reagent (usually Lipofectamin P3000 from Invitrogen, USA) to transfect DNA into the cells from both the groups, and incubate for 24 h at 370C and 5% CO2: 95% Air environment inside an incubator.

iii.Treat group ii with extract or natural compound for further 24–48 h.

iv.After the treatment is over, fix the cells in 4% paraformaldehyde for 15 min.

v.Stain cells with Hoechst 33342 or DAPI (Sigma) to stain nucleus.


Analysis of fluorescent images: Both RFP and GFP fluoresces on autophagosomes as LC3B and represents as yellow puncta in overlay under basal condition. However, in autolysosome, under acidic/low pH GFP (green) fluorescence get quenched and only RFP fluorescence can be visualized as red puncta (in overlay) of autolysosome suggesting increase in autophagy flux. Similarly, both RFP and GFP fluoresces on mitochondria and whole mitochondrial network can be visualized under basal condition. However, in mitophagolysosome, under acidic/low pH GFP (green) fluorescence get quenched and only RFP fluorescence will be visualized as red puncta (in overlay) of mitophagolysosome suggesting increase in mitophagy flux.

*2.2.3 Analysis of lipophagy by fluorescence microscopy*

Introduction and principle: To analyze lipophagy (autophagic degradation of lipids), cellular lipid droplets/triglycerides stain using BODIPY™ 493/503 dye (Invitrogen) and endogenous LC3B proteins stain using anti-LC3B antibody. Fluorescence microscopy analysis is performed to analyze co-localization of lipids/ BODIPY with LC3B.

Methodology:


iii.After the treatment is over, fix the cells in 4% paraformaldehyde for 15 min.

iv.Wash cells with 1x phosphate buffer saline (PBS) three times 5 min each.


Analysis of fluorescent images: Both BODIPY™ fluorescence is visualized using GFP/Annexin filter to observe green fluorescence of lipid droplets, however, RFP filter can be used to visualize LC3B red fluorescence. Lipophagy will be seen in overlay as yellow puncta formed by BODIPY-LC3B co-localization.

### *2.2.4 Analysis of autophagy, lipophagy, and mitophagy by electron microscopy*

Introduction and principle: Electron microscopy is one of the best methods for the detection of autophagy and quantification of autophagic accumulation compared to fluorescence microscopy that has lower resolution than transmission electron microscopy [41]. During autophagy induction, the number of degradative compartments increases and the quantification of the number of autophagosome, autolysosomes, lysosomes, and amphisomes per cell section provides a simple morphological readout. But, it is very difficult to distinguish between autolysosomes, lysosomes, and amphisomes, hence, it is much simpler to classify all these organelles together, as degradative compartments or autophagic vesicles. However, autophagosome and autolysosome can be distinguished by observing their double membrane vs. single membrane walls respectively.

Methodology:


In Vitro *Assessment of Antioxidant Capacity, Potential to Induce Autophagy/Mitophagy… DOI: http://dx.doi.org/10.5772/intechopen.112278*


Application: Autophagy plays a key role in the cellular maintenance and development of disease [38, 43]. Impairment in autophagic removal of damaged mitochondria (mitophagy) and fatty acids/lipids (lipophagy) has been shown to be important in various pathological states including neurodegenerative diseases and metabolic disorders [38, 43]. Recently, phytochemicals have been shown to be an autophagy inducers and are beneficial in various diseases and metabolic disorders [44–47]. Hence, analyzing autophagy flux and their potential to remove damaged mitochondria and lipids can be an easy way to evaluate plant's therapeutic efficacy.

## **2.3 Assessment of mitochondrial turnover (synthesis of new and removal of damaged mitochondria) using MitoTimer**

Introduction and principle: Fluorescent Timer, or DsRed, is a mutant of the red fluorescent protein, dsRed, in which fluorescence shifts over time from green to red as the protein matures or undergoes oxidation during the course of aging.

This molecular clock gives temporal and spatial information on protein turnover [48]. To monitor mitochondrial turnover, this Timer is engineered and tagged with mitochondrial-targeting sequence (called as "MitoTimer") and cloned in a plasmid. When cells get MitoTimer, it localizes in the mitochondria and disappearance of red fluorescence (for removal of damaged mitochondria) and appearance of green mitochondrial (for synthesis of new mitochondria) i.e. turnover, can be visualized. Methodology:


Analysis of fluorescent images: As shown in the [49], both mitoRFP and mitoGFP fluoresces on mitochondria and represented as yellow mitochondrial network in overlay under basal condition, suggesting mitochondrial homeostasis. However, when there is an increase in mitochondrial turnover by mitophagy, mitoGFP (green) fluorescence increases and mitoRFP fluorescence decreases under (A) treatment X suggesting increase in new mitochondria via biogenesis and removal of old/damaged mitochondria by mitophagy. Similarly, when turnover is decreased, both mitoRFP increases and mitoGFP decreases suggesting decreased mitochondrial biogenesis and accumulation of damaged/aged mitochondria under (B) treatment X.

Application: Mitochondrial turnover is utmost important to maintain mitochondrial homeostasis that is required for cellular health [5, 50]. Dysregulated mitochondrial turnover leads to cause oxidative stress and cell death which is a major cause for metabolic disorders and cancer [24, 26, 51]. Study of mitochondrial turnover using MitoTIMER assay is a convenient method to evaluate phytochemicals efficacy.

#### **2.4 Assessment of cell viability/cytotoxicity** *in vitro*

## *2.4.1 MTT tetrazolium assay*

Principle: Tetrazolium salts are widely used for detecting redox potential of cells for viability, cytotoxicity, and proliferation assays. This is a colorimetric assay that

In Vitro *Assessment of Antioxidant Capacity, Potential to Induce Autophagy/Mitophagy… DOI: http://dx.doi.org/10.5772/intechopen.112278*

measures the reduction of yellow 3-(4,5-dimethythiazol2-yl)-2,5-diphenyl tetrazolium bromide (MTT) by mitochondrial succinate dehydrogenase, which demonstrates functional mitochondria [52]. The MTT is cell permeable and goes into the mitochondria and gets reduced to purple colored formazan crystals. These purple crystals are then solubilized using organic solvent. Lastly, this purple solution is measured spectrophotometrically. Notably, reduction of MTT only occurs in metabolically active cells, thus, the level of purple color is a measure of the viable cells.

Methodology:


#### *2.4.2 MTS assay*

Principle: Colorimetric method for sensitive quantification of viable cells in proliferation and cytotoxicity assay. This assay is also based on the same principle as MTT assay, where we read colored formazan product by metabolically active cells is soluble in cell culture media. The MTS assay offers a number of advantages over the MTT assay. First, it eliminates the need for washing or solubilization steps, making it a more efficient and streamlined process. This high-throughput assay can be performed directly in the cell culture media, and can be conducted using a 96-well microtiter plate. The MTS assay is versatile and can be used to measure cell proliferation in response to a variety of stimuli, such as growth factors, cytokines, mitogens, and nutrients. Additionally, it is useful for analyzing the cytotoxic effects of compounds such as anticancer drugs, as well as other toxic agents, and pharmaceuticals.

Methodology:


for further 24–48 h, and incubate at 370C and 5% CO2: 95% Air environment inside an incubator.


#### *2.4.3 Luciferase-based assay for real-time cytotoxicity analysis*

Principle: The latest innovation in viable cell number measurement is a real-time approach using a pro-substrate and luciferase. This method involves adding the reagent directly to the culture medium, where viable cells with active metabolism reduce the pro-substrate into a Luc-substrate. The Luc-substrate then diffuses into the culture medium, and luciferase utilizes it to generate a luminescent signal.

The pro-substrate is non-reactive with luciferase and is well-tolerated by cells, remaining stable in complete cell culture medium at 37°C for at least 72 hours. This long-term stability allows for multiple measurements from the same sample over a period of days without the need for pro-substrate replenishment.

The assay can be performed in both continuous-read and endpoint formats. In continuous-read mode, the luminescent signal is recorded repeatedly from the same sample wells over an extended period to measure the number of viable cells in real time. This new approach provides a reliable and efficient way to monitor viable cell numbers and metabolic activity in a variety of research applications [53].

### Methodology:

RealTime-GloTM MT Cell Viability Assay (Promega) for continuous read mode:


In Vitro *Assessment of Antioxidant Capacity, Potential to Induce Autophagy/Mitophagy… DOI: http://dx.doi.org/10.5772/intechopen.112278*

Application: Analysis of cell viability plays a diverse role in establishing the relationship between drug safety and its toxicity. High-throughput methods are very well embraced in the scientific community for drug's safety evaluation tastings. Hence, above-mentioned cytotoxicity/cell viability assays are best fit to titrate the safe dosage of phytochemicals.

## **3. Discussion**

One of the important and attractive uses of the *in vitro* methods is to evaluate therapeutic efficacy and safety of active compounds/phytochemicals and/or crude extracts in a high-throughput manner, and that also limits the use of animals which can be expensive, labor-intensive, and time taking. The most common assays (as mentioned above in Section 2.1) are to evaluate antioxidant potential of herbal extracts or active compounds in a cell-free system or by using animal cell culture system. Prof. Y. Osumi has received Noble prize for re-stating the role of autophagy in cell health and disease [54]. Technological advancements in scientific field further made it possible to evaluate autophagic flux and related processes, such as mitophagy and lipophagy, in a high-throughput way by using fusion proteins (as discussed above in Sections 2.2 and 2.4) in animal cell culture system. Mitochondrial dysfunction and de-regulation of mitochondrial turnover and homeostasis play key roles in may diseases including cancer. Analysis of OCR that is an indicator of mitochondrial respiration and mitochondrial activity is utmost important for safety evaluation plant-based therapeutic compounds. Recently developed engineered mitochondrialocalized fluorescent proteins [48], that aged or oxidized in time-dependent manner and fluoresce differentially (as discussed above in Section 2.3) are boon for new age research, can be used to evaluate mitochondrial turnover in a high-throughput way. Cytotoxicity is desirable in the cancer-targeted drugs; however, it can be detrimental for normal cells, so analysis of cytotoxicity is important for successful use of plant-based chemo-drugs or to target metabolic diseases. Although, there are several high-throughput assays available for assessing the potential cell viability and cytotoxicity of plant extracts and phytochemicals, this chapter (in Section 2.5) provides a summary of both commonly used and recently developed cell-free and cell-based assays. These assays serve as important tools for evaluating the safety and therapeutic effectiveness of plant-based drugs and compounds.

## **Acknowledgements**

The authors are thankful to the Ministry of Health (MOH), and National Medical Research Council (NMRC), Singapore, for financial assistance grant number NMRC/ OFYIRG/0002/2016 and MOH-000319 (MOH-OFIRG19may-0002) to BKS; NMRC/ OFYIRG/077/2018 to MT; and CSAI19may-0002 to PMY.

## **Conflict of interest**

The authors declare no conflict of interest.

## **Notes/thanks/other declarations**

None.

## **Author details**

Madhulika Tripathi1 \*, Manish Kumar Verma2 and Brijesh Kumar Singh1 \*

1 Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, Singapore

2 Raghuveer Singh Government (P.G.) College, Lalitpur, Uttar Pradesh, India

\*Address all correspondence to: madhulika.tripathi@duke-nus.edu.sg and singhbrijeshk@duke-nus.edu.sg

© 2023 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In Vitro *Assessment of Antioxidant Capacity, Potential to Induce Autophagy/Mitophagy… DOI: http://dx.doi.org/10.5772/intechopen.112278*

## **References**

[1] Molaei E et al. Nephroprotective activity of natural products against chemical toxicants: The role of Nrf2/ ARE signaling pathway. Food Science & Nutrition. 2021;**9**(6):3362-3384

[2] Nejabati HR, Roshangar L. Kaempferol as a potential neuroprotector in Alzheimer's disease. Journal of Food Biochemistry. 2022;**46**(12):e14375

[3] Rolt A, Cox LS. Structural basis of the anti-ageing effects of polyphenolics: Mitigation of oxidative stress. BMC Chemistry. 2020;**14**(1):50

[4] Sapian S et al. Role of polyphenol in regulating oxidative stress, inflammation, fibrosis, and apoptosis in diabetic nephropathy. Endocrine, Metabolic & Immune Disorders Drug Targets. 2022;**22**(5):453-470

[5] Kakkar P, Singh BK. Mitochondria: A hub of redox activities and cellular distress control. Molecular and Cellular Biochemistry. 2007;**305**(1-2):235-253

[6] Singh S et al. Nrf2-ARE stress response mechanism: A control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radical Research. 2010;**44**(11):1267-1288

[7] Ying M, Hu X. Tracing the electron flow in redox metabolism: The appropriate distribution of electrons is essential to maintain redox balance in cancer cells. Seminars in Cancer Biology. 2022;**87**:32-47

[8] Andres CMC et al. Superoxide anion chemistry-its role at the Core of the innate immunity. International Journal of Molecular Sciences. 2023;**24**(3):1841

[9] Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated

mechanisms: A radical therapeutic approach? Nature Reviews. Drug Discovery. 2009;**8**(7):579-591

[10] Ascensao A et al. Modulation of hepatic redox status and mitochondrial metabolism by exercise: Therapeutic strategy for liver diseases. Mitochondrion. 2013;**13**(6):862-870

[11] Baffy G. Mitochondrial uncoupling in cancer cells: Liabilities and opportunities. Biochimica et Biophysica Acta - Bioenergetics. 2017;**1858**(8):655-664

[12] Georgieva D, Egli D. Tying genetic stability to cell identity. Cell Cycle. 2017;**16**(12):1139-1140

[13] Akbari B et al. The role of plantderived natural antioxidants in reduction of oxidative stress. BioFactors. 2022;**48**(3):611-633

[14] Antonio Pereira I et al. Traditional plants used in southern Brazil as a source to wound healing therapies. Chemistry & Biodiversity. 2023:e202201021

[15] Jalali J, Ghasemzadeh Rahbardar M. Ameliorative effects of Portulaca oleracea L. (purslane) and its active constituents on nervous system disorders: A review. Iranian Journal of Basic Medical Sciences. 2023;**26**(1):2-12

[16] Kamkin V et al. Comparative analysis of the efficiency of medicinal plants for the treatment and prevention of COVID-19. International Journal of Biomaterials. 2022;**2022**:5943649

[17] Tarmizi NM et al. Genus Lepisanthes: Unravelling its botany, traditional uses, phytochemistry, and pharmacological properties. Pharmaceuticals (Basel). 2022;**15**(10):1261

[18] Huang PL. A comprehensive definition for metabolic syndrome. Disease Models & Mechanisms. 2009;**2**(5-6):231-237

[19] Lemieux I, Despres JP. Metabolic syndrome: Past, present and future. Nutrients. 2020;**12**(11):3501

[20] Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: Still emerging. Cell Metabolism. 2022;**34**(3):355-377

[21] Ali M et al. Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions. Phytotherapy Research. 2018;**32**(2):199-215

[22] Martinez-Outschoorn UE et al. Cancer metabolism: A therapeutic perspective. Nature Reviews. Clinical Oncology. 2017;**14**(1):11-31

[23] Rodic S, Vincent MD. Reactive oxygen species (ROS) are a key determinant of cancer's metabolic phenotype. International Journal of Cancer. 2018;**142**(3):440-448

[24] Bhatti JS, Bhatti GK, Reddy PH. Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies. Biochimica et Biophysica Acta - Molecular Basis of Disease. 2017;**1863**(5):1066-1077

[25] Chan DC. Mitochondrial dynamics and its involvement in disease. Annual Review of Pathology. 2020;**15**:235-259

[26] Gaude E, Frezza C. Defects in mitochondrial metabolism and cancer. Cancer & Metabolism. 2014;**2**:10

[27] Picca A et al. Mitochondrial dysfunction, oxidative stress, and neuroinflammation: Intertwined roads to neurodegeneration. Antioxidants (Basel). 2020;**9**(8):647

[28] Picca A et al. Mitochondrial dysfunction and aging: Insights from the analysis of extracellular vesicles. International Journal of Molecular Sciences. 2019;**20**(4):805

[29] Falzon CC, Balabanova A. Phytotherapy: An introduction to herbal medicine. Primary Care. 2017;**44**(2): 217-227

[30] Tillotson AK. Essential concepts and vocabulary in herbal medicine. Journal of Dietary Supplements. 2008;**5**(4):411-421

[31] Padmavathi G et al. Butein in health and disease: A comprehensive review. Phytomedicine. 2017;**25**:118-127

[32] Waltenberger B et al. Natural products to counteract the epidemic of cardiovascular and metabolic disorders. Molecules. 2016;**21**(6):807

[33] Rice-Evans CA. Measurement of total antioxidant activity as a marker of antioxidant status in vivo: Procedures and limitations. Free Radical Research. 2000;**33**(Suppl):S59-S66

[34] Feelisch M, Noack EA. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. European Journal of Pharmacology. 1987;**139**(1):19-30

[35] El Assar M, Angulo J, Rodriguez-Manas L. Oxidative stress and vascular inflammation in aging. Free Radical Biology & Medicine. 2013;**65**:380-401

[36] Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension. 2017;**70**(4):660-667

In Vitro *Assessment of Antioxidant Capacity, Potential to Induce Autophagy/Mitophagy… DOI: http://dx.doi.org/10.5772/intechopen.112278*

[37] Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nature Reviews. Molecular Cell Biology. 2020;**21**(7):363-383

[38] Sinha RA, Singh BK, Yen PM. Reciprocal crosstalk between autophagic and endocrine Signaling in metabolic homeostasis. Endocrine Reviews. 2017;**38**(1):69-102

[39] Harnett MM et al. From Christian de Duve to Yoshinori Ohsumi: More to autophagy than just dining at home. Biomedical Journal. 2017;**40**(1):9-22

[40] Klionsky DJ et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1). Autophagy. 2021;**17**(1):1-382

[41] Yla-Anttila P et al. Monitoring autophagy by electron microscopy in mammalian cells. Methods in Enzymology. 2009;**452**:143-164

[42] Wyffels, J.T., Principles and Techniques of Electron Microscopy: Biological Applications, Fourth edition, by M. A. Hayat. Microscopy and Microanalysis, 2001. 7(1): p. 66

[43] Galluzzi L et al. Molecular definitions of autophagy and related processes. The EMBO Journal. 2017;**36**(13):1811-1836

[44] Moosavi MA et al. Phytochemicals as potent modulators of autophagy for cancer therapy. Cancer Letters. 2018;**424**:46-69

[45] Nabavi SF et al. Regulation of autophagy by polyphenols: Paving the road for treatment of neurodegeneration. Biotechnology Advances. 2018;**36**(6):1768-1778

[46] Sinha RA et al. Caffeine stimulates hepatic lipid metabolism by the

autophagy-lysosomal pathway in mice. Hepatology. 2014;**59**(4):1366-1380

[47] Zhou J et al. Epigallocatechin-3 gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance. PLoS One. 2014;**9**(1):e87161

[48] Hernandez G et al. MitoTimer: A novel tool for monitoring mitochondrial turnover. Autophagy. 2013;**9**(11):1852-1861

[49] Singh BK et al. Thyroid hormone receptor and ERRalpha coordinately regulate mitochondrial fission, mitophagy, biogenesis, and function. Science Signaling. 2018;**11**(536):eaam5855

[50] Peinado JR et al. Mitochondria in metabolic disease: Getting clues from proteomic studies. Proteomics. 2014;**14**(4-5):452-466

[51] Amorim JA et al. Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nature Reviews. Endocrinology. 2022;**18**(4):243-258

[52] Gerlier D, Thomasset N. Use of MTT colorimetric assay to measure cell activation. Journal of Immunological Methods. 1986;**94**(1-2):57-63

[53] Riss TL, Moravec RA, Niles AL. Cytotoxicity testing: Measuring viable cells, dead cells, and detecting mechanism of cell death. Methods in Molecular Biology. 2011;**740**:103-114

[54] Fullgrabe J et al. Transcriptional regulation of mammalian autophagy at a glance. Journal of Cell Science. 2016;**129**(16):3059-3066

Section 3
